BIOA vs IP · rev $9.0M vs P/E 43, $26.62B cap
BioAge Labs, Inc (BIOA) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
IP does not have a complete income-statement cache yet.
BIOA currently screens at market cap $697.9M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the BIOA and IP stock pages for the full models.
Not investment advice.